Hatami Solyman, Maturi Vamsi, Mathew Alwin, Lu Shannon, Haddad Paul, Sheikh Daanish, Rahimi Maham
Texas A&M School of Engineering Medicine, Houston, TX.
Department of Cardiovascular Surgery, Houston Methodist, Houston, TX.
J Vasc Surg Cases Innov Tech. 2024 Aug 20;10(6):101599. doi: 10.1016/j.jvscit.2024.101599. eCollection 2024 Dec.
Endovascular aortic repair (EVAR) graft failure can be as high as 16% to 30% owing to endoleak, graft migration, or infection, often necessitating explantation, leading to potential morbidity (31%) and mortality (6.3%). Graft prongs frequently tear through the endothelium during explantation, leading to endothelial damage and subsequent fatal bleeding. The current standard of care involves different suboptimal techniques such as the syringe technique in which a cylinder is improvised by cutting a syringe in half and pushed over the graft hooks in a rotating motion, until covered for manual explantation. Because there is no commercially available product to address this shortcoming in graft explantation, we engage in the biodesign process to produce a functional explantation device. We designed and prototyped multiple potential solutions to remove EVAR endografts safely. Silicone tubing with EVAR endografts deployed in the lumen were used to simulate a grafted aorta and test each prototype. Prototypes were compared in their ability to meet design criteria including decrease in graft diameter, prevention of arterial dissection, ease of use, and decrease in procedure time. After determining the single best prototype, surgeon feedback was elicited to iteratively improve the original design. The most effective design uses a tapered lumenal geometry that decreases the EVAR graft diameter and uses stainless steel beads to prevent shear stress to the simulated aorta. A distal grip allows for easy single hand manipulation of the device, while a latching mechanism allows for smooth placement and removal over the endograft. After rigorous prototyping, our device proved feasible and effective for safe EVAR explantation, allowing this procedure to be performed safely.
由于内漏、移植物移位或感染,血管腔内主动脉修复(EVAR)移植物失败率可高达16%至30%,常常需要进行移植物切除,这会导致潜在的发病率(31%)和死亡率(6.3%)。在移植物切除过程中,移植物的叉头经常会撕裂内皮,导致内皮损伤及随后的致命性出血。当前的治疗标准涉及不同的欠佳技术,例如注射器技术,即将注射器切成两半临时制作一个圆柱体,然后以旋转方式推过移植物挂钩,直至覆盖以便手动切除。由于没有可用于解决移植物切除这一缺点的市售产品,我们开展了生物设计流程来生产一种功能性切除装置。我们设计并制作了多个潜在解决方案的原型,以安全移除EVAR腔内移植物。将内腔中部署有EVAR腔内移植物的硅胶管用于模拟植入移植物的主动脉并测试每个原型。对原型在满足设计标准的能力方面进行比较,包括移植物直径减小、预防动脉夹层、易用性和手术时间缩短。在确定最佳单一原型后,征求外科医生的反馈以迭代改进原始设计。最有效的设计采用锥形内腔几何结构,可减小EVAR移植物直径,并使用不锈钢珠来防止对模拟主动脉产生剪切应力。远端手柄便于单手轻松操作该装置,而锁定机构可实现腔内移植物的顺利放置和移除。经过严格的原型制作,我们的装置被证明对于安全的EVAR切除是可行且有效的,使得该手术能够安全进行。